Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study.

@article{Delmas2006IntravenousII,
  title={Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study.},
  author={Pierre Dominique Delmas and Silvano Adami and Cezary Strugala and Jacob Andreas Stakkestad and J -Y Reginster and Dieter Felsenberg and Claus Christiansen and Roberto Civitelli and Marc Drezner and Robert Roy Recker and Michael Bolognese and Claire E Hughes and Daiva Masanauskaite and Penelope Ward and Philip Sambrook and David M. Reid},
  journal={Arthritis and rheumatism},
  year={2006},
  volume={54 6},
  pages={1838-46}
}
OBJECTIVE Although oral bisphosphonates are effective treatments for postmenopausal women with osteoporosis, oral dosing may be unsuitable for some patients. An efficacious intravenously administered bisphosphonate could be beneficial for such patients. Ibandronate, a potent nitrogen-containing bisphosphonate, can be administered using extended dosing intervals, either orally or by rapid intravenous injection. The aim of this study was to identify the optimal intravenous dosing regimen for… CONTINUE READING

From This Paper

Topics from this paper.
81 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 81 extracted citations

Similar Papers

Loading similar papers…